Brief: Design Therapeutics Q4 Basic EPS USD -0.27
09/03/2026 20:01
Mar 09 (Reuters) - Design Therapeutics Q4 operating expenses USD 18.169 million. Q4 operating income USD -18.169 million Q4 net income USD -15.997 million vs. IBES estimate USD -20.3 million
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1